FDA's New Framework Limits COVID-19 Vaccines for Younger Populations
FDA approved Pfizer's updated COVID-19 boosters on August 27, 2025 Limited vaccine access for children and younger adults Shift from annual shots for everyone over 6 months to higher-risk groups Rescinded emergency use authorizations for some vaccines, especially Pfizer's pediatric shots under 5 Robert F. Kennedy Jr. stated changes align with ending mandates and maintaining access for high-risk individuals.